Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination-Reference-Cited by-同舟云学术

Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination

Published:2014-12 Issue: Volume:196 Page:122-131
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Fonseca Nuno A.,Gomes-da-Silva Lígia C.,Moura Vera,Simões Sérgio,Moreira João Nuno

Funder

Portuguese Foundation for Science and Technology (FCT)

InovC/UC (2013)

Sistemas de Bolsas de Ignição do Programa Estratégico Inov C financiado pelo QREN, no âmbito do Mais Centro - Programa Operacional Regional do Centro, QREN/FEDER/COMPETE

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Cancer statistics, 2013;Siegel;CA Cancer J. Clin.,2013

3. Drug resistance in chemotherapy for breast cancer;Saeki;Cancer Chemother. Pharmacol.,2005

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo;Dicko;Expert Opin. Drug Deliv.,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review);International Journal of Molecular Medicine;2023-07-21

2. Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy;Journal of Drug Delivery Science and Technology;2023-03

3. Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma;Cancers;2022-10-14

4. Nanoparticles Targeting and Uptake: Current Advances in Breast Cancer Research;Breast Cancer: Current Trends in Molecular Research;2022-07-14

5. Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer;Cancers;2022-04-29